Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Emerald Health Therapeutics Inc (EMHTF)

$1.28 0.05 (3.87%)

15:58 EDT EMHTF Stock Quote Delayed 15 Minutes

Volume:

Previous Close $1.28

Market Cap 80.37M

PE Ratio -

EPS -

Volume (Avg. Vol.) 231,000

Day's Range 1.27 - 1.35

52-Week Range 1.25 - 4.18

Dividend & Yield N/A (N/A)

EMHTF Stock Predictions, Articles, and Emerald Health Therapeutics Inc News

From InvestorPlace
From the Web

7 Marijuana Penny Stocks That I May Buy

By Mark Putrino, CMT Aug 19, 2019

Most companies that have stocks that trade for pennies are doomed. These seven marijuana companies are penny stocks, but they may survive.

10 Medical Marijuana Stocks to Cure Your Portfolio

By Josh Enomoto, InvestorPlace Contributor Aug 12, 2019

Although recreational weed captures headlines, the real money is on broadly accepted medicinal marijuana stocks.

10 Marijuana Stocks to Ride High on the Farm Bill

By Josh Enomoto, InvestorPlace Contributor Dec 21, 2018

Marijuana stocks have recently lagged the markets, but the newly signed farm bill provides a significant catalyst for pot businesses.

8 Pot Stocks That Can Rise Above Marijuana Controversies

By Josh Enomoto, InvestorPlace Contributor Aug 3, 2018

Many investors have shied away from investing in pot stocks and the marijuana industry, but their profitability potential is undeniable.

Why Village Farms International Looks Like a Great Buy Today

From The Motley Fool Sep 14, 2019

The cannabis stock has many partnerships that can help position it for significant growth down the road.

7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk

From InvestorPlace Sep 10, 2019

Investing in marijuana penny stocks can be very profitable but it can also be very risky. Here are seven to consider.

Emerald Health Therapeutics Announces Closing of $25 million Convertible Debenture Unit Financing

From MarketJar Sep 10, 2019

This Post Was Syndicated Under License Via QuoteMedia NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 10, 2019 (GLOBE NEWSWIRE) ... Read

FDA OKs Boehringer Ingelheim's Ofev for rare lung disease

From Seeking Alpha Sep 6, 2019

The FDA approves privately held Boehringer Ingelheim's Ofev (nintedanib) to slow the rate of decline in pulmonary function in adult patients with interstitial lung disease associated with systemic scl

The Week Ahead In Cannabis: Delta 9 Uplisting, MJBizCon INT'L & More

From Benzinga Sep 3, 2019

The week ahead will be shorter due to Labor Day , but it won't be short in events and developments surrounding the cannabis industry. Here are some of the highlights of the...

The Week In Cannabis: Moves From The DEA, FDA, USDA; New York Fashion Week; And Quarterly Reports

From Benzinga Sep 1, 2019

This week, the U.S. Drug Enforcement Administration said it will expand the number of federal licenses for the research of cannabis; the Food and Drug Administration re-...

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!